capsaicin and sorafenib

capsaicin has been researched along with sorafenib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Dong, LY; Du, C; Gao, JJ; Ni, YH; Qiao, Z; Sun, JY; Wang, K; Wang, LY; Yu, HX; Zhang, JH; Zhang, SS; Zhao, CR1
Chen, H; Dai, N; Guo, P; He, Q; Ye, R; Zhang, Q1
Badarau, IA; Caruntu, C; Constantin, C; Didilescu, AC; Mihai, GL; Neagu, M; Scheau, C1

Reviews

1 review(s) available for capsaicin and sorafenib

ArticleYear
Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma.
    Molecules (Basel, Switzerland), 2019, Jun-26, Volume: 24, Issue:13

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Capsaicin; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Drug Synergism; Humans; Liver Neoplasms; Neovascularization, Pathologic; Oxidative Stress; Signal Transduction; Sorafenib; TRPV Cation Channels

2019

Other Studies

3 other study(ies) available for capsaicin and sorafenib

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.
    Acta pharmacologica Sinica, 2018, Volume: 39, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capsaicin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Niacinamide; Phenylurea Compounds; Sorafenib; Xenograft Model Antitumor Assays

2018
Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling.
    Oncology reports, 2018, Volume: 40, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capsaicin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018